Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Janux Therapeutics Inc (NASDAQ: JANX) was $53.92 for the day, up 1.28% from the previous closing price of $53.24. In other words, the price has increased by $1.28 from its previous closing price. On the day, 0.66 million shares were traded. JANX stock price reached its highest trading level at $54.56 during the session, while it also had its lowest trading level at $52.52.
Ratios:
Our analysis of JANX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 38.80 and its Current Ratio is at 38.80. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 03, 2024, Reiterated its Buy rating but revised its target price to $70 from $63 previously.
On December 03, 2024, BTIG Research reiterated its Buy rating and also lowered its target price recommendation from $82 to $100.
On November 22, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $79.Leerink Partners initiated its Outperform rating on November 22, 2024, with a $79 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 02 ’25 when Meyer Andrew Hollman sold 13,334 shares for $54.88 per share. The transaction valued at 731,785 led to the insider holds 82,139 shares of the business.
ANDREW MEYER bought 13,334 shares of JANX for $713,902 on Jan 02 ’25. On Dec 24 ’24, another insider, Campbell David Alan, who serves as the President and CEO of the company, sold 25,000 shares for $56.19 each. As a result, the insider received 1,404,805 and left with 217,054 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JANX now has a Market Capitalization of 3161480448 and an Enterprise Value of 2195107328. For the stock, the TTM Price-to-Sale (P/S) ratio is 241.87 while its Price-to-Book (P/B) ratio in mrq is 4.30. Its current Enterprise Value per Revenue stands at 168.22 whereas that against EBITDA is -26.169.
Stock Price History:
Over the past 52 weeks, JANX has reached a high of $71.71, while it has fallen to a 52-week low of $7.79. The 50-Day Moving Average of the stock is -1.20%, while the 200-Day Moving Average is calculated to be 13.44%.
Shares Statistics:
JANX traded an average of 974.76K shares per day over the past three months and 731060 shares per day over the past ten days. A total of 52.34M shares are outstanding, with a floating share count of 47.02M. Insiders hold about 18.65% of the company’s shares, while institutions hold 78.42% stake in the company. Shares short for JANX as of 1734048000 were 6414759 with a Short Ratio of 6.58, compared to 1731628800 on 4185628. Therefore, it implies a Short% of Shares Outstanding of 6414759 and a Short% of Float of 19.520001.
